Technicians at Chinese vaccine maker Sinovac Biotech in Wuhan. Improvements in technology and greater access to markets and capital are making it easier for small and medium-sized companies to grow into tomorrow’s behemoths. Photo: Reuters
Technicians at Chinese vaccine maker Sinovac Biotech in Wuhan. Improvements in technology and greater access to markets and capital are making it easier for small and medium-sized companies to grow into tomorrow’s behemoths. Photo: Reuters